A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery

Completed · Phase 2

Conditions studied: Arthroplasty, Replacement, Knee

In brief

To evaluate the safety and efficacy of twice daily dosing and once daily dosing of YM150 in subjects undergoing primary elective knee replacement surgery

Key facts

Study ID

NCT00595426

Run by

Astellas Pharma Inc

People needed

685

Starts

2008-05-01

Expected to finish

2009-05-01

Last updated by the study team

2013-03-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is scheduled for elective primary knee arthroplasty
• Written Informed consent obtained

You may not qualify if…

• Subject has documented history of previous VTE
• Subject is considered to be at increased risk of VTE
• Subject has active bleeding or any condition associated with increased risk of bleeding
• Subject is planning to have surgery on the contralateral knee at the same time or within 6 weeks after enrollment into the study

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Tuscon, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Fountain Valley, California, United States
• Study site — La Mesa, California, United States
• Study site — Long Beach, California, United States
• Study site — Long Beach, California, United States
• Study site — San Diego, California, United States
• Study site — Santa Ana, California, United States
• Study site — Torrance, California, United States
• Study site — Yuba City, California, United States
• Study site — Aurora, Colorado, United States
• Study site — Denver, Colorado, United States
• Study site — Lone Tree, Colorado, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Bay Pines, Florida, United States
• Study site — Bradenton, Florida, United States
• Study site — Gulf Breeze, Florida, United States
• Study site — Hollywood, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Decatur, Georgia, United States
• Study site — Savannah, Georgia, United States
• Study site — Boise, Idaho, United States
• Study site — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.